Gene ID | Gene Symbol | Description | Source |
---|---|---|---|
2260 | FGFR1 | fibroblast growth factor receptor 1 | |
2322 | FLT3 | fms related receptor tyrosine kinase 3 | |
2624 | GATA2 | GATA binding protein 2 | |
2821 | GPI | glucose-6-phosphate isomerase | |
2876 | GPX1 | glutathione peroxidase 1 | |
3078 | CFHR1 | complement factor H related 1 | |
3119 | HLA-DQB1 | major histocompatibility complex, class II, DQ beta 1 | |
3417 | IDH1 | isocitrate dehydrogenase (NADP(+)) 1 | |
3418 | IDH2 | isocitrate dehydrogenase (NADP(+)) 2 | |
3552 | IL1A | interleukin 1 alpha |
Gene ID | Gene Symbol | Description | Source |
---|---|---|---|
11350 | Abl1 | c-abl oncogene 1, non-receptor tyrosine kinase | |
12317 | Calr | calreticulin | |
12402 | Cbl | Casitas B-lineage lymphoma | |
12477 | Ctla4 | cytotoxic T-lymphocyte-associated protein 4 | |
12524 | Cd86 | CD86 antigen | |
12550 | Cdh1 | cadherin 1 | |
12654 | Chi3l1 | chitinase 3 like 1 | |
12767 | Cxcr4 | C-X-C motif chemokine receptor 4 | |
12981 | Csf2 | colony stimulating factor 2 (granulocyte-macrophage) | |
12985 | Csf3 | colony stimulating factor 3 (granulocyte) |
Gene ID | Gene Symbol | Description | Source |
---|---|---|---|
60628 | Cxcr4 | C-X-C motif chemokine receptor 4 | |
79114 | Fgfr1 | Fibroblast growth factor receptor 1 | |
83502 | Cdh1 | cadherin 1 | |
83571 | Cdkn1b | cyclin-dependent kinase inhibitor 1B | |
83785 | Vegfa | vascular endothelial growth factor A | |
89816 | Picalm | phosphatidylinositol binding clathrin assembly protein | |
89824 | Chi3l1 | chitinase 3 like 1 | |
116630 | Csf2 | colony stimulating factor 2 | |
140668 | Abcc3 | ATP binding cassette subfamily C member 3 | |
246097 | Fas | Fas cell surface death receptor |
Gene ID | Gene Symbol | Description | Source |
---|---|---|---|
31926 | Idgf4 | Imaginal disc growth factor 4 | |
32661 | if | inflated | |
32877 | htk | hat-trick | |
34978 | Idgf1 | Imaginal disc growth factor 1 | |
34979 | Idgf2 | Imaginal disc growth factor 2 | |
34981 | Idgf3 | Imaginal disc growth factor 3 | |
35886 | Pgi | Phosphoglucose isomerase | |
36868 | Idgf6 | Imaginal disc growth factor 6 | |
37104 | Idgf5 | Imaginal disc growth factor 5 | |
37859 | enok | enoki mushroom |
Gene ID | Gene Symbol | Description | Source | Organism |
---|---|---|---|---|
373579 | kit.L | KIT proto-oncogene receptor tyrosine kinase L homeolog | Xenopus laevis (African clawed frog) | |
380373 | cxcr4.S | C-X-C motif chemokine receptor 4 S homeolog | Xenopus laevis (African clawed frog) | |
397782 | fgfr1.S | fibroblast growth factor receptor 1 S homeolog | Xenopus laevis (African clawed frog) | |
399444 | fgfr1.L | fibroblast growth factor receptor 1 L homeolog | Xenopus laevis (African clawed frog) | |
548648 | fgfr1 | fibroblast growth factor receptor 1 | Xenopus tropicalis (tropical clawed frog) | |
100038176 | cxcr4 | C-X-C motif chemokine receptor 4 | Xenopus tropicalis (tropical clawed frog) | |
100192360 | cxcr4.L | C-X-C motif chemokine receptor 4 L homeolog | Xenopus laevis (African clawed frog) | |
100337618 | cdh1.S | cadherin 1, type 1 S homeolog | Xenopus laevis (African clawed frog) |
Gene ID | Gene Symbol | Description | Source |
---|---|---|---|
172813 | npp-14 | Nuclear pore complex protein 14 | |
175182 | ver-1 | Protein ver-1 | |
175504 | pat-3 | Integrin beta pat-3 | |
176240 | pat-2 | Integrin alpha pat-2 | |
180408 | mrp-2 | Multidrug resistance-associated protein 1 | |
180409 | mrp-1 | Multidrug resistance-associated protein 1 | |
180628 | cht-1 | putative endochitinase | |
181178 | gpx-5 | Glutathione peroxidase | |
182513 | gpx-3 | Glutathione peroxidase 3 | |
186632 | ver-4 | Tyrosine-protein kinase receptor ver-4 |
HPO ID | HPO Term |
---|---|
HP:0000006 | Autosomal dominant inheritance |
HP:0001442 | Typified by somatic mosaicism |
HP:0004808 | Acute myeloid leukemia |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.1.0
Last updated: December 9, 2024